bimekizumab
ucb biopharma
['izokibep', 'bimekizumab', 'risan', '#hs ', 'psoriasis', 'hidradenitis']
#hidradenitis and #psoriasis are the order of the day at #aad2023. what excites me today? #bimekizumab - phase 3 #hs data! finally!
#izokibep - another potential #il17 based treatment for hs! yes!
#risankizumab - new #switching data from il17 blockers! count me in ! 
Assistant Professor of Dermatology | Director of Center for Eczema and Itch | Northwestern University | Treating inflammatory diseases across shades of skin